Product image of Heparine Natrium B. Braun (Heparin Sodium) supplied by GNH India

Heparine Natrium B. Braun

Active Ingredient:
Heparin Sodium
Origin:
EU

Heparine Natrium B. Braun (Heparin Sodium)

Heparine Natrium B. Braun is a pharmaceutical product that contains the active ingredient heparin sodium. It is supplied as an injectable solution for intravenous administration, with the specific strength not disclosed in the available data. Classified as an anticoagulant and antithrombotic, this prescription‑only medication is marketed in the European Union and is used under medical supervision to manage clot‑related conditions.

Manufacturer / TM Owner

B.Braun Melsungen Ag

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Heparine Natrium B. Braun is indicated for several clinical situations where anticoagulation is required. It is commonly employed in the prevention and treatment of venous thromboembolic events.

  • Prevention of venous thromboembolism in postoperative or immobilized patients
  • Treatment of acute deep vein thrombosis (DVT)
  • Management of pulmonary embolism (PE)
  • Anticoagulation during cardiac surgery, including cardiopulmonary bypass
  • Anticoagulation for patients undergoing hemodialysis or other extracorporeal circuits

Side Effects

Heparine Natrium B. Braun may cause a range of adverse reactions, most of which are related to its anticoagulant activity.

Common

  • Minor bleeding at injection site
  • Hematuria (blood in urine)
  • Epistaxis (nosebleeds)
  • Gastrointestinal irritation or mild abdominal discomfort
  • Elevated liver enzymes (transient)

Serious

  • Major hemorrhage (intracranial, gastrointestinal, or surgical site)
  • Heparin‑induced thrombocytopenia (HIT)
  • Allergic reactions including anaphylaxis
  • Spontaneous spinal or epidural hematoma

Precautions & Warnings

Before initiating therapy with Heparine Natrium B. Braun, clinicians should evaluate patient‑specific risk factors and monitor relevant parameters.

  • Assess baseline coagulation status (aPTT, PT/INR) and platelet count
  • Review history of bleeding disorders, recent surgery, or trauma
  • Use caution in patients with renal or hepatic impairment
  • Avoid use in individuals with known hypersensitivity to heparin or pork products
  • Monitor for signs of heparin‑induced thrombocytopenia during treatment
  • Adjust dose or discontinue if uncontrolled bleeding occurs

Avoid Interactions

Heparine Natrium B. Braun can interact with other agents that affect hemostasis or platelet function.

Avoid

  • Concurrent use of other anticoagulants (e.g., warfarin, direct oral anticoagulants) without close monitoring
  • Thrombolytic agents (e.g., alteplase, streptokinase)
  • High‑dose aspirin or non‑steroidal anti‑inflammatory drugs (NSAIDs) that increase bleeding risk

Use with caution

  • Antiplatelet drugs such as clopidogrel or dipyridamole
  • Selective serotonin reuptake inhibitors (SSRIs) and other serotonergic agents
  • Glycoprotein IIb/IIIa inhibitors
  • Certain antibiotics (e.g., cefotetan) that may potentiate anticoagulant effect

Frequently Asked Questions

Heparine Natrium B. Braun contains heparin sodium, which potentiates antithrombin III. This enhances inhibition of thrombin (factor IIa) and factor Xa, reducing clot formation.

It is commonly prescribed for prevention of venous thromboembolism, treatment of acute deep vein thrombosis, management of pulmonary embolism, and anticoagulation during cardiac surgery or dialysis.

The product is administered intravenously as an injectable solution under the supervision of a healthcare professional.

Activated partial thromboplastin time (aPTT) is the primary test for monitoring anticoagulant effect; platelet counts are also checked to detect heparin‑induced thrombocytopenia.

No. Patients with known hypersensitivity to heparin or pork‑derived products should not receive Heparine Natrium B. Braun.

Serious bleeding may present as unexplained bruising, blood in urine or stool, vomiting blood, severe headache, or neurological changes suggesting intracranial hemorrhage.

The pregnancy safety category is not specified; clinicians must weigh potential benefits against risks and follow local guidelines when considering use in pregnant patients.

If HIT is suspected, heparin therapy should be stopped immediately and an alternative non‑heparin anticoagulant should be considered.

There are no specific dietary restrictions, but patients should avoid foods or supplements that may increase bleeding risk, such as high‑dose vitamin K or herbal products with anticoagulant properties.

Concurrent use of aspirin can increase the risk of bleeding; clinicians should monitor the patient closely or adjust therapy as appropriate.

The product should be stored according to the manufacturer’s label, typically at controlled room temperature away from light and moisture.

Dose adjustments or increased monitoring may be necessary in patients with significant renal dysfunction, as clearance of heparin can be affected.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Heparin Sodium

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT